Impact of depressive symptoms on oxidative stress in patients with psoriasis

Redox Report

Volumn 18, Issue 2, 2013, Pages 51-55

  Karababa, Fatih ^a   Yesilova, Yavuz ^a   Turan, Enver ^a   Selek, Salih ^a   Altun, Hacer ^a   Selek, Sahabettin ^a  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Depressive symptoms; Oxidative stress index; Psoriasis disease

Indexed keywords

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; BLOOD SAMPLING; CHEMICAL PARAMETERS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PSORIASIS; TOTAL ANTIOXIDANT CAPACITY; TOTAL OXIDANT CAPACITY;

ADOLESCENT; ADULT; ANTIOXIDANTS; ANXIETY DISORDERS; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; PSORIASIS; YOUNG ADULT;

EID: 84876303381     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000213Y.0000000039     Document Type: Article

References (44)

1. Kimball AB, Wu EQ, Guérin A, Yu AP, Tsaneva M, Gupta SR, et al. Risks of developing psychiatric disorders in paediatric patients with psoriasis. J Am Acad Dermatol 2012;67(4):651-7.
2. Rieder E, Tausk F. Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol 2012;51(1):12-26.
3. Akay A, Pekcanlar A, Bozdag KE, Altintas L, Karaman A. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002;16(4): 347-52.
4. Glassman SJ. Vitiligo, reactive oxygen species and T-cells. Clin Sci (Lond) 2011;120(3):99-120.
5. Jain A, Mal J, Mehndiratta V, Chander R, Patra SK. Study of oxidative stress in vitiligo. Indian J Clin Biochem 2011;26(1): 78-81.
6. Briganti S, Picardo M: Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol 2003;17(6):663-9.
7. Jalel A, Hamdaoui MH. Study of total antioxidant capacity and glutathione peroxidase activity in Tunisian vitiligo patients. Indian J Dermatol 2009;54(1):13-6.
8. Passi S, Grandinetti M, Maggio F, Stancato A, De Luca C. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998; 11(2):81-5.
9. Kadam DP, Suryakar AN, Ankush RD, Kadam CY, Deshpande KH. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem 2010;25(4):388-92.
10. Halliwell B. Oxidative stress and neurodegeneration: where are we now. J Neurochem 2006;97(6):1634-58. Review.
11. Bilici M, Efe H, Köroǧlu MA, Uydu HA, Bekaroǧlu M, Deǧer O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001;64(1):43-51.
12. Bowling A. Measuring disease. Buckingham: Open University Press; 1995.
13. Zigmon AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scand 1983;67:361-70.
14. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of hospital anxiety and depression scale: an updated literature review. J Psychosomatic Res 2002;52:69-77.
15. Martin CR, Tweed AE, Metcalfe MS. A psychometric evaluation of the hspital anxiety and depression scale in patients diagnosed with end-stage renal disease. Br J Clin Psychol 2004;43:51-64.
16. Aydemir O, Guvenir T, Kuey L, Kultur S. Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk Psikiyatr Derg 1997;8:280-7.
17. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112-9.
18. Erel O. A new automated colorimetric method for measuring total oxidant capacity. Clin Biochem 2005;38(12):1103-11.
19. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998;44(11):2313-9.
20. Vanizor Kural B, Örem A, Çimşit GU, Yandi YE, Calapǒglu M. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidantantioxidant system in patients with psoriasis. Clinica Chimica Acta 2003;328(1-2): 71-82.
21. Gabr SA, Al-Ghadir AH. Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Arch Dermatol Res 2012;304(6):451-7.
22. Okayama Y. Oxidative stress in allergic and inflammatory skin diseases. Curr Drug Targets 2005;4(4):517-9.
23. Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 2009;47(7): 891-905.
24. Sikar Aktürk A, Ozdoǧan HK, Bayramgürler D, Cekmen MB, Bilen N, Kiran R. Nitric oxide and malondialdehyde levels in plasma and tissue of psoriasis patients. J Eur Acad Dermatol Venereol 2012;26(7):833-7.
25. Hashemi M, Mehrabifar H, Daliri M, Ghavami S. Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis. J Eur Acad Dermatol Venereol 2010; 24(3):329-34.
26. Yildirim M, Inaloz HS, Baysal V, Delibas N. The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venereol 2003;17(1):34-6.
27. Mercan S, Altunay Kivaç I. Psikiyatri ve dermatolojinin ortak çali{dotless}şma alani{dotless}: psikodermatoloji. Türk Psikiyatri Dergisi 2006; 17(4):305-13.
28. Parafianowicz K, Sicińska J, Moran A, Szumański J, Staniszewski K, Rudnicka L, et al. Psychiatric comorbidities of psoriasis: pilot study. Psychiatr Pol 2010;44(1):119-26.
29. Han C, Lofland JH, Zhao N, Schenkel B. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis. J Drugs Dermatol 2011;10(8):843-50.
30. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010;146(8): 891-5.
31. Russo PAJ, Ilchef R, Cooper AJ, Psychiatric morbidity of psoriasis:a rewiev. Australias J Dermatol 2004;45:155-61.
32. Akay A, Pekcanlar A, Bozdaǧ KE, Altintaş L, Karaman A. Assesment of depression in subject with psoriasis and lichen planus. JEDAV 2002;16:347-352.
33. Schmitt JM, Ford DE. Role of depression in quality of life for patients with psoriasis. Dermatology 2007;215:17-27.
34. Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther 2008;21:54-9.
35. Fried RG, Friedman S, Paradis C, Hatch M, Lynfield Y, Duncanson C, et al. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995;34(2):101-5.
36. Gupta MA, Gupta AK. Psoriasis and sex: A study of moderately to severely affected patients. Int J Dermatol 1997;36:259-62.
37. Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S. An Italian study on psoriasis and depression. Dermatology. 2006;212:123-7.
38. Ceprnja M, Derek L, Unić A, Blazev M, Fistonić M, Kozarić-Kovacić D, et al. Oxidative stress markers in patients with post-traumatic stress disorder. Coll Antropol 2011;35(4): 1155-60.
39. Salustri C, Squitti R, Zappasodi F, Ventriglia M, Bevacqua MG, Fontana M, et al. Oxidative stress and brain glutamate-mediated excitability in depressed patients. J Affect Disord 2010;127(1-3): 321-5.
40. Delibaş N, Özcankaya R, Özgüner MF, Boz F. The relationship between cognitive status changes, depressive and psychotic symptoms and free radical activity. Türk Psikiyatri Derg 1996; 1:46-52.
41. Stefanescu C, Ciobica A. The relevance of oxidative stress status in first episode and recurrent depression. J Affect Disord 2012; 143(1-3):34-8.
42. Gibson SA, Korade Ž, Shelton RC. Oxidative stress and glutathione response in tissue cultures from persons with major depression. J Psychiatry Res 2012;46(10):1326-32.
43. Michel TM, Pülschen D, Thome J. The role of oxidative stress in depressive disorders. Curr Pharm Des 2012;18(36): 5890-9.
44. Misery L. Depression and psoriasis. Ann Dermatol Venereol 2012;139(Suppl 2):S53-7.